BioMarin Pharma (BMRN) PT Jumps To $120 On 2 Solid New Growth Drivers - Piper Jaffray
August 3, 2018 7:20 AM
Piper Jaffray analyst, Christopher Raymond, reiterated his Overweight rating on shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and raised his ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
